Stocktwits on MSN
Ultragenyx stock eyes best day in 17 months as Wall Street shifts focus to 2026 pipeline after bone disease trial miss
Analysts cut price targets after the Phase 3 miss but largely maintained positive ratings and highlighted secondary endpoint ...
The New Republic on MSNOpinion
The Private Equity Firms That Gobble Up Hospitals and Spit Them Out
Looking to turn a quick profit, the firms buy medical facilities and then unload them just a few years later, often leaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback